PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 99 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $6,799,000 | -19.3% | 3,316,614 | +3.9% | 0.91% | -20.6% |
Q4 2017 | $8,424,000 | -63.7% | 3,191,095 | -27.9% | 1.14% | -68.3% |
Q3 2017 | $23,226,000 | +27.0% | 4,424,063 | -13.8% | 3.61% | +4.8% |
Q2 2017 | $18,281,000 | -28.4% | 5,135,000 | +3.9% | 3.44% | +31.0% |
Q1 2017 | $25,549,000 | +1.2% | 4,941,712 | +75.4% | 2.63% | -24.5% |
Q3 2016 | $25,249,000 | +105.7% | 2,818,004 | +61.5% | 3.48% | +84.3% |
Q2 2016 | $12,275,000 | +114.1% | 1,744,896 | +11.4% | 1.89% | +150.6% |
Q3 2015 | $5,732,000 | -26.1% | 1,566,056 | -0.8% | 0.75% | -13.1% |
Q3 2014 | $7,753,000 | -22.1% | 1,579,097 | -1.9% | 0.87% | -18.1% |
Q2 2014 | $9,950,000 | +85.4% | 1,610,075 | +60.5% | 1.06% | +11.9% |
Q1 2014 | $5,367,000 | -18.7% | 1,003,147 | -20.5% | 0.95% | -21.9% |
Q4 2013 | $6,602,000 | +18.4% | 1,262,266 | +25.0% | 1.21% | +26.1% |
Q3 2013 | $5,576,000 | +112.9% | 1,010,066 | -2.4% | 0.96% | +38.3% |
Q2 2013 | $2,619,000 | – | 1,035,066 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,398,861 | $31,097,000 | 3.12% |
ORACLE INVESTMENT MANAGEMENT INC | 3,241,761 | $18,673,000 | 2.27% |
BOURNE LENT ASSET MANAGEMENT INC | 152,575 | $879,000 | 0.69% |
Trellus Management Company, LLC | 95,800 | $552,000 | 0.62% |
MAVERICK CAPITAL LTD | 7,061,034 | $40,672,000 | 0.62% |
Iguana Healthcare Management, LLC | 275,000 | $1,584,000 | 0.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,485,861 | $8,559,000 | 0.28% |
Spark Investment Management LLC | 159,400 | $916,000 | 0.13% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 147,052 | $847,000 | 0.13% |
EverPoint Asset Management, LLC | 900,010 | $5,184,000 | 0.10% |